Interestingly, the use of CX-5461 to affect rDNA transcription and ribosome biogenesis not only in nucleolus but also in mitochondrion seems to be a possible strategy to combat c-Myc-driven cancers (Rossetti et al. 2018). This evidence concerns the gene MYC and cancer.